NCT07090486View on ClinicalTrials.gov

A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.

CompletedOBSERVATIONAL
Enrollment

14,000

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

April 15, 2025

Study Completion Date

April 15, 2025

Conditions
COVID-19
Interventions
DRUG

nirmatrelvir-ritonavir

Paxlovid standard of treatment care

Trial Locations (1)

10001

Pfizer New York, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT07090486 - A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions. | Biotech Hunter | Biotech Hunter